Article Details
Retrieved on: 2021-09-30 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AC Immune is co-developing semorinemab alongside Genentech, a Roche company. In the brains of people with Alzheimer's, a protein called tau forms abnormal “ ...
Article found on: alzheimersnewstoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here